{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-26-040823","form_type":"8-K","ticker":"COO","cik":"0000711404","company_name":"COOPER COMPANIES, INC.","filed_at":"2026-06-04T20:27:28+00:00","discovered_at":"2026-06-04T20:28:00.205745+00:00","generated_at":"2026-06-04T20:59:38.066060+00:00","sec_items":["2.02","8.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.9,"calibrated_materiality_score":0.9,"confidence":"high","headline":"CooperCompanies Q2 revenue $1.082B (+8% YoY); non-GAAP EPS $1.21 (+26%); records $271.6M litigation charge","bullets":["Revenue $1.082B (+8% reported, +5% organic); CooperVision $723.5M (+8%), CooperSurgical $358.0M (+8%).","GAAP diluted EPS of $(0.40) due to $271.6M net litigation charge; non-GAAP diluted EPS $1.21, up 26% YoY.","Recorded $271.6M net charge ($324.1M liabilities less $52.5M insurance) for CooperSurgical fertility media recall; settled >95% of over 1,500 claimants.","Fiscal 2026 guidance: revenue $4.285-$4.321B; non-GAAP diluted EPS $4.58-$4.66; reaffirms long-term free cash flow target >$2.2B for FY26-28.","Repurchased $13.1M in common stock (174k shares) at avg $75.84; $860.8M remaining under buyback authorization."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-26-040823","json":"https://secwatch.observer/filing/0001628280-26-040823.json","markdown":"https://secwatch.observer/filing/0001628280-26-040823.md","text":"https://secwatch.observer/filing/0001628280-26-040823.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/711404/000162828026040823/0001628280-26-040823-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/711404/000162828026040823/coo-20260604.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-04T20:59:38.066060+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"003b864a6fe71dc30b357be2202db023afc973c7","claim":"COOPER COMPANIES, INC. reported fiscal year 2026 results: revenue $4.285 - $4.321 billion, EPS $4.58 - $4.66.","evidence_excerpt":"The Company updated its fiscal year 2026 financial guidance. Details are summarized as follows: • Fiscal 2026 total revenue of $4.285 - $4.321 billion (organic growth of 3.5% to 4.5%) • CVI revenue of $2.883 - $2.908 billion (organic growth of 3.5% to 4.5%) • CSI revenue of $1.402 - $1.414 billion (organic growth of 4% to 5%) • Fiscal 2026 non-GAAP diluted EPS of $4.58 - $4.66 • Reaffirm previously communicated long-term free cash flow objective exceeding $2.2 billion for fiscal years 2026 through 2028","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/711404/000162828026040823/0001628280-26-040823-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"fiscal year 2026"},{"label":"Revenue","value":"$4.285 - $4.321 billion"},{"label":"EPS","value":"$4.58 - $4.66"},{"label":"Result","value":"guidance update"}],"fact_type":"earnings_release"},{"claim_id":"f9372b365c4632be7472085b6ef552bbfc416672","claim":"COOPER COMPANIES, INC. reported fiscal second quarter ended April 30, 2026 results: revenue $1.082 billion, EPS $(0.40) per diluted share.","evidence_excerpt":"• Second quarter 2026 revenue of $1.082 billion, up 8%, or up 5% organically, from last year's second quarter. • Second quarter 2026 GAAP diluted earnings per share (EPS) of $(0.40), down $0.84 from last year's second quarter driven by a litigation-related charge to resolve outstanding claims associated with a December 2023 voluntary product recall at CooperSurgical. • Second quarter 2026 Non-GAAP diluted EPS of $1.21, up $0.25 or 26% from last year's second quarter.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/711404/000162828026040823/0001628280-26-040823-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"fiscal second quarter ended April 30, 2026"},{"label":"Revenue","value":"$1.082 billion"},{"label":"EPS","value":"$(0.40) per diluted share"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}